{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T02:54:59Z","timestamp":1778122499240,"version":"3.51.4"},"reference-count":37,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2001,12,21]],"date-time":"2001-12-21T00:00:00Z","timestamp":1008892800000},"content-version":"vor","delay-in-days":203,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Immunology"],"published-print":{"date-parts":[[2001,6]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Chemokines participate in the regulation of leucocyte recruitment in a wide variety of inflammatory processes, including host defence and diseases such as asthma, atherosclerosis and autoimmune disorders. We have previously described the properties of Peptide 3, the first broad\u2010specificity chemokine inhibitor <jats:italic>in vitro<\/jats:italic>. Here, we report the properties of NR58\u20103.14.3, a retroinverso analogue of Peptide 3. NR58\u20103.14.3 inhibited leucocyte migration induced by a range of chemokines, including monocyte chemoattractant protein\u20101 (MCP\u20101) (2\u00b75\u2003n<jats:sc>m<\/jats:sc>), macrophage inflammatory protein\u20101\u03b1 (MIP\u20101\u03b1) (5\u2003n<jats:sc>m<\/jats:sc>), regulated on activation, normal T\u2010cell expressed and presumably secreted (RANTES) (20\u2003n<jats:sc>m<\/jats:sc>), stromal cell\u2010derived factor\u20101\u03b1 (SDF\u20101\u03b1) (25\u2003n<jats:sc>m<\/jats:sc>) and interleukin\u20108 (IL\u20108) (30\u2003n<jats:sc>m<\/jats:sc>), but did not affect migration induced by <jats:italic>N<\/jats:italic>\u2010formyl\u2010methionyl\u2010leucyl\u2010phenylalanine (FMLP) or complement C5a (&gt;\u2003100\u2003\u00b5<jats:sc>m<\/jats:sc>). NR58\u20103.14.3 is therefore \u2248\u200a1000\u2010fold more potent than Peptide 3 but retains the broad\u2010spectrum chemokine inhibitory activity of the parent peptide. <jats:italic>In vivo<\/jats:italic>, pretreatment with a systemic dose of 10\u2003mg of NR58\u20103.14.3, but not the inactive derivative NR58\u20103.14.4, abolished leucocyte recruitment in response to intradermal injection of 500\u2003ng of MCP\u20101 into rat skin. This suggests that NR58\u20103.14.3 is a functional chemokine inhibitor <jats:italic>in vivo<\/jats:italic> as well as <jats:italic>in vitro<\/jats:italic>. We utilized NR58\u20103.14.3 as a tool to investigate the role of chemokine activity during leucocyte recruitment in response to lipopolysaccharide (LPS) <jats:italic>in vivo<\/jats:italic>. NR58\u20103.14.3, but not NR58\u20103.14.4, abolished leucocyte recruitment in response to intradermal injection of 50\u2003ng of LPS into rat skin. Furthermore, NR58\u20103.14.3 completely inhibited LPS\u2010induced accumulation of tumour necrosis factor\u2010\u03b1 (TNF\u2010\u03b1). This data is consistent with a model in which multiple chemokines act in parallel upstream of TNF\u2010\u03b1. NR58\u20103.14.3 is therefore a powerful anti\u2010inflammatory agent <jats:italic>in vivo<\/jats:italic>, suppressing proinflammatory cytokine production and leucocyte recruitment in response to endotoxin stimulus in rat skin.<\/jats:p>","DOI":"10.1046\/j.1365-2567.2001.01228.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T02:29:05Z","timestamp":1047436145000},"page":"244-254","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["The pan\u2010chemokine inhibitor NR58\u20103.14.3 abolishes tumour necrosis factor\u2010\u03b1 accumulation and leucocyte recruitment induced by lipopolysaccharide <i>in vivo<\/i>"],"prefix":"10.1111","volume":"103","author":[{"given":"Jill","family":"Reckless","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren M.","family":"Tatalick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Grainger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,21]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-4547(19960815)45:4<340::aid-jnr3>3.0.co;2-9"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0165-6147(99)01308-5"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0167-5273(98)00147-8"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.67.5.591"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/11.2.217"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.2000.00720.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.118.2.503"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.67.2.149"},{"key":"e_1_2_6_10_2","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.4049\/jimmunol.151.12.6692","article-title":"Protein tyrosine kinase activation is required for lipopolysaccharide induction of cytokines in human blood monocytes","volume":"151","author":"Geng Y","year":"1993","journal-title":"J Immunol"},{"key":"e_1_2_6_11_2","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.4049\/jimmunol.155.3.1515","article-title":"Macrophage inflammatory protein\u20101 alpha mediates lung leukocyte recruitment, lung capillary leak, and early mortality in murine endotoxemia","volume":"155","author":"Standiford TJ","year":"1995","journal-title":"J Immunol"},{"key":"e_1_2_6_12_2","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.4049\/jimmunol.154.4.1900","article-title":"Compartmentalized expression of RANTES in a murine model of endotoxemia","volume":"154","author":"VanOtteren GM","year":"1995","journal-title":"J Immunol"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119475"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.173.4.1029"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.59.8.2774-2780.1991"},{"key":"e_1_2_6_16_2","first-page":"279","article-title":"Differential expression of interleukin\u20101 and tumor necrosis factor in murine septic shock models","volume":"29","author":"Evans GF","year":"1989","journal-title":"Circ Shock"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/163.6.1177"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/33340"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199802123380706"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1042\/0264-6021:3400803"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm9906264"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M000692200"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M001222200"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-1128(200003)20:2<155::AID-MED3>3.0.CO;2-G"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm990211i"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/368744a0"},{"key":"e_1_2_6_27_2","first-page":"171","article-title":"A micro technique for endotoxin assay by using Limulus lysate","volume":"36","author":"Flowers DJ","year":"1979","journal-title":"Med Lab Sci"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1177\/44.9.8773570"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.11.4120"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1159\/000023825"},{"key":"e_1_2_6_31_2","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.4049\/jimmunol.152.3.1298","article-title":"Macrophage inflammatory protein\u20101 alpha and monocyte chemoattractant peptide\u20101 elicit immediate and late cutaneous reactions and activate murine mast cells in vivo","volume":"152","author":"Alam R","year":"1994","journal-title":"J Immunol"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115950"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/382829a0"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0021-9150(99)00346-9"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830271122"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.276.5310.276"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V78.4.1112.1112"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1006\/abio.1999.4437"}],"container-title":["Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2567.2001.01228.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2567.2001.01228.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T18:38:59Z","timestamp":1697654339000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2567.2001.01228.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["10.1046\/j.1365-2567.2001.01228.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2567.2001.01228.x","archive":["Portico"],"relation":{},"ISSN":["0019-2805","1365-2567"],"issn-type":[{"value":"0019-2805","type":"print"},{"value":"1365-2567","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,6]]},"assertion":[{"value":"2001-12-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}